CN Patent

CN1898221A — Atp－结合弹夹转运蛋白的调控剂

Assigned to Vertex Pharmaceuticals Inc · Expires 2007-01-17 · 19y expired

What this patent protects

本发明涉及ATP－结合弹夹(ABC)转运蛋白或其片段、包括CF跨膜调节剂(CFTR)的调控剂、其组合物和与之有关的方法。本发明也涉及使用这类调控剂治疗ABC转运蛋白介导的疾病的方法。

USPTO Abstract

本发明涉及ATP－结合弹夹(ABC)转运蛋白或其片段、包括CF跨膜调节剂(CFTR)的调控剂、其组合物和与之有关的方法。本发明也涉及使用这类调控剂治疗ABC转运蛋白介导的疾病的方法。

Drugs covered by this patent

Kalydeco (IVACAFTOR) · Vertex Pharms Inc

Patent Metadata

Patent number: CN1898221A
Jurisdiction: CN
Classification: —
Expires: 2007-01-17
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.